Behind IBM’s Autonomous Chemistry Lab

With no stoppage of the COVID pandemic within the foreseeable future, drug discovery has been a crucial concern for the healthcare business. But, in actuality, it takes round a decade with roughly $10 million to find a brand new drug, get it examined and convey it to the market. Such a delayed course of might be majorly attributed to the tedious technique of repetitive experiments to deliver out the drug. Thus, to omit this important hurdle in drug discovery, IBM has launched an autonomous chemistry lab combining AI, robotics and cloud know-how — RoboRXN.

A cloud-based AI mannequin, RoboRXN has been developed to carry out autonomously, like a robotic, utilizing machine studying algorithms to supply chemical compounds and medicines in a laboratory with little to no human intervention. Not solely a growth like that may optimise the drug discovery course of by decreasing the manufacturing time, however also can decrease down the price, permitting scientists to deliver out new medicine in well being crises, holding the norms of social distancing in place.

Teodoro Laino, a researcher at IBM, said within the company blog that chemists and scientists depend on conventional processes in discovering medicine and different chemical compounds, and little progress has been made to modernise these processes of trial and error. And subsequently, IBM has automated this course of to speed up materials discovery.

Also Read: Google’s New Machine Learning-Based Initiative For Accelerated Drug Discovery

Overview Of IBM’s Autonomous Lab

According to the weblog submit by Laino, the event of RoboRXN initiated when IBM started engaged on growing ML fashions to foretell chemical reactions and provided it as a free service — referred to as it as RXN for Chemistry. The device leveraged neural machine studying translation methodology for predicting the product of the chemical reactions, utilizing the SMILE illustration to determine chemical entities.

Using SMILE illustration, this molecule is translated into BrCCOC1OCCCC1

However, mixing all these elements and experimenting with the trial and error strategies with all of the parts was nonetheless time-consuming. And thus, in an try to cut back that, IBM mixed AI with cloud and automation know-how to deliver our RoboRXN, as a remotely accessible lab for higher manufacturing of medicine. 

Launched as an internet device — RoboRXN works by an internet browser, the place the scientists can use the clean canvas to sort and draw the required “skeletal structure of the molecular compounds.” With that info, the web platform makes use of ML algorithms to foretell the parts wanted and study the best technique of synthesising the weather. To facilitate this, the corporate designed the algorithm to exactly extract the required synthesis info and transformed the identical in a machine-readable format. This info is then despatched to a robotic positioned within the impartial lab to execute the method. The platform additionally sends a real-time report back to the scientists with the outcomes.

PC: IBM Research

RoboRXN additional claimed on the corporate weblog that it doesn’t rely its workings on particular person entities of sentences, nor does it require to be talked about on the phrases that want corresponding actions. This, in flip, permits the mannequin to be extra versatile and correct. Furthermore, so as to present information enter for the ML mannequin, the corporate additionally developed an annotation framework that generated examples on a wide range of sentences with “synthesis procedures and corresponding operations.”

See Also

Moreover, IBM claims that RoboRXN for predicting reactions can simply outstrip all different data-driven fashions with 90% accuracy. To construct the response dataset, the corporate extracted the chemical info utilizing NLP referred to as Molecular Transformer. When requested, Laino defined, within the firm weblog, the significance of cleansing up the information so as to obtain an correct prediction mannequin.

The mannequin has been skilled on numerous chemical recipes and in addition been designed to study the specifics of chemical compounds so as to suggest the right sequence of the parts. Not solely RoboRXN is {hardware} agnostic, but in addition envelopes AI know-how to execute a fancy collection of chemical procedures. With its cloud-native design, it has been designed to be accessed from wherever remotely.

Also Read: Artificial Intelligence swarms drug discovery. Is India catching up too?

Wrapping Up

Claiming to revolutionise industrial chemistry, the launch of RoboRXN, with its dependable outcomes, might be extraordinarily useful for drug discovery amid this COVID pandemic. The mixture of robotics, together with synthetic intelligence and cloud, cannot solely cut back the time of the invention course of but in addition create extra emphasis on design and innovation. With this growth, it’s hoped to be useful for researchers and chemists with the brand new remedy for COVID-19 or any future viruses attainable. 

Provide your feedback under


If you really liked this story, do be part of our Telegram Community.

Also, you’ll be able to write for us and be one of many 500+ specialists who’ve contributed tales at AIM. Share your nominations here.

Sejuti Das

Sejuti at the moment works as Senior Technology Journalist at Analytics India Magazine (AIM). Reach out at


Please enter your comment!
Please enter your name here